{"url_path":"/sec/lbrx/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/1691082/0001193125-26-219607-index.html","accession_number":"0001193125-26-219607","cik":"0001691082","ticker":"LBRX","issuer_name":"LB PHARMACEUTICALS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1691082/0001193125-26-219607-index.html","primary_entity_key":"0001691082","primary_entity_name":"LB PHARMACEUTICALS INC"},"word_count":57,"has_tables":true,"body_markdown":"Item 1. Legal Proceedings.\n\nFrom time to time, we may become involved in legal proceedings arising in the ordinary course of our business. We do not have any pending litigation that, separately or in the aggregate, would, in the opinion of management, have a material adverse effect on our results of operations, financial condition, or cash flows."}